FDA
approval
· 2022-12-23
FDA Approved: CAVERJECT — Supplemental Application (Pharmacia & Upjohn Company LLC)
Summary
FDA approved a supplemental application for CAVERJECT (alprostadil) submitted by Pharmacia & Upjohn Company LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CAVERJECT (ALPROSTADIL)